Good morning, ladies and gentlemen, welcome to the MAV Beauty Brands second quarter 2023 earnings call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star and then 0 for the operator. This call is being recorded on Wednesday, August 9th, 2023. The remarks today may provide certain information regarding MAV's expectations, future plans, and intentions that may constitute forward-looking statements. Please reference the most recent filed AIF and the MD&A for the second quarter, which are available on the company's website and on the SEDAR. These include a summary of the significant assumptions underlying these forward-looking statements and the risks that could affect the company's performance and the ability to deliver on these forward-looking statements. With that, I'll turn it over to Mr. Jureidini, CEO of MAV. Thank you, Mark. Good morning, and welcome to MAV's second quarter conference call. I'm joined by Laurel MacKay-Lee, our Chief Financial Officer. I will briefly cover the operational results before Laurel reviews the financial highlights. As we have discussed over the past several quarters, our top-line results have been impacted by reduced distribution, mainly in the U.S. mass and drug channels. Sales for Q2 were $20.7 million, a decrease of 19% over the prior year, and distribution losses for more than offset strong performance in e-commerce and growth in Canada. As we look at brand performance year to date, one of our brands, the largest, is directionally flat, while the others are down from 2022 levels, with one showing stronger declines from a reduced footprint in the U.S. mass channel. Taken together, the portfolio results fell short of the broader US market category, which posted high single-digit dollar growth for the period. Our team continues to make good progress on our innovation and marketing plans as we work to strengthen each of our brands and position the MAV portfolio for improved results moving forward with our complementary collection of authentic and differentiated brands. With Marc Anthony, we are building on our well-established Strictly Curls and Grow Long collections through innovation, while pursuing opportunities in new categories where we can make salon-quality products accessible to our channel consumers. Our Repair Bond collection, which was introduced earlier this year with select retailers, continues to generate positive consumer feedback, and we're seeing gradual increases in POS run rates. We are sustaining awareness marketing campaign this summer and this fall as we work to establish Repair Bond as the new core collection. With Renpure, our priority this year is a successful brand relaunch. We have introduced a new master brand design, sustainable packaging, and new formulas with the most stringent clean standards. We believe this gives us a strong foundation to rebuild the brand's distribution and establish it over time as a key player within conscious beauty. All major accounts have now transitioned to the new packaging, and our marketing campaign is ramping up. With Cake, we are focused on innovation and accelerating digitization, particularly growth on Amazon. A high-value strategic collaboration is set to launch in the coming weeks. Our team is very excited to see this come to life as it should generate great brand awareness and potentially serve as a blueprint for other collaborations. We'll share more once the campaign is in market. Lastly, with The Mane Choice, one of the main priorities is simplified product assortment, with collections built around key star products such as the Alpha Growth Oil, our top overall SKU for this brand. As with other brands, innovation is a priority, and we have compelling new launches planned for 2024. We're also focused on engaging with our social community, which has historically been the strength of the brand. For the MAV portfolio overall, we continue to see strong results in e-commerce, namely Amazon. Sales grew by double digits in the second quarter, and we believe this channel will continue to be an important growth area for the portfolio. Separately, our team has also been working diligently on operational improvements and efficiencies, and we're making steady progress across the key initiatives. We're encouraged by the sequential improvements in Adjusted EBITDA, cash flow, and working capital in our Q2 results. In addition to the immediate cost reductions, these efforts should give us a stronger foundation upon which to scale and grow the business. I will now ask Laurel to cover the financial highlights, the financials in greater detail. Thank you, Serge. Good morning, and thank you for joining us today. As Serge highlighted, net sales decreased from $25.4 million last year to $20.7 million this quarter, principally reflecting the impact of previously disclosed distribution losses in the US mass and drug channels. Q2 2023 gross profit decreased by 13% to $9.3 million, compared to $10.8 million in Q2 2022, reflecting the sales decline. Gross profit margin was 45.1%, increased from 42.4% in the second quarter last year. The improvement benefits from the impact of $595,000 in business interruption insurance proceeds that were received during the quarter related to a claim for a cybersecurity breach at the company's primary third-party logistics partner in February 2022. Overall, we continue to make headway on improving cost of sales to combat the impact of inflation with the supply chains. Q2 Adjusted EBITDA decreased to $2.7 million from $3.5 million in the same period last year, mainly reflecting lower revenue and gross profit. Cash generation improved, with free cash flow increasing to $1.9 million from $1.3 million last year, driven by the decrease in non-cash working capital in the quarter. We reported a higher net loss in the current period of $2.2 million versus net income of $0.3 million in Q2 2022. The year-over-year change reflects the softer operating results, as well as higher interest and accretion expense due to an increase in variable rates and incremental payment-in-kind interest added as part of the sixth amendment to the credit facility in March. In addition, we incurred additional expenses related to the strategic review process initiated during the quarter. This process is ongoing. Lastly, at quarter end, our cash position was CAD 8.2 million, and net debt was CAD 116.8 million. Thank you for joining us this morning, and thanks again to the whole MAV team. We greatly appreciate your efforts. Now, Mark, would you please open up the call for questions? Thank you. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press star followed by 1 on your touchtone phone. You'll hear a three-tone prompt acknowledging your request. If you'd like to withdraw your request, please press star followed by 2. If you're using a speakerphone, please lift the handset before any keys. One moment, please, for the first question. Okay, there seem to be no questions coming through at this time, so with that, we'll now conclude the conference. Ladies and gentlemen, thank you for calling in today. We thank you for your particip-participation and ask that you please disconnect your lines.